EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Targeted inhibition of colorectal cancer proliferation: The dual‐modulatory role of 2, 4‐DTBP on anti‐apoptotic Bcl‐2 and Survivin proteins

Partha Saha, Mangala Hegde, Kanak Chakraborty, Achinta Singha, Nobendu Mukerjee iD, Deepshikha Ghosh, Ajaikumar B Kunnumakkara, Mohd Shahnawaz Khan, Md Irshad Ahmad, Arabinda Ghosh iD, Ajoy Kumer iD, Samir Kumar Sil

Journal of Cellular and Molecular Medicine · 2024-04 · 28 (7)

DOI: 10.1111/jcmm.18150 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, online erschienen am 17.03.2024. Verfasst von Partha Saha und 11 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Genetics and Cell Physiology Laboratory, Department of Human Physiology, Tripura University, Suryamaninagar, Tripura, India. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Phenols. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The anti‐apoptotic proteins, Bcl‐2 and Survivin, are consistently overexpressed in numerous human malignancies, notably in colorectal cancer. 2,4‐Di‐tert‐butylphenol (2,4‐DTBP) is a naturally occurring phenolic compound known for its diverse biological activities, including anti‐cancer properties. The mechanism behind 2,4‐DTBP‐induced inhibition of cell proliferation and apoptosis in human colorectal cancer cells, specifically regarding Bcl‐2 and Survivin, remains to be elucidated. In this study, we employed both in silico and in vitro methodologies to underpin this interaction at the molecular level. Molecular docking demonstrated a substantial binding affinity of 2,4‐DTBP towards Bcl‐2 (Δ G = −9.8 kcal/mol) and Survivin (Δ G = −5.6 kcal/mol), suggesting a potential inhibitory effect. Further, molecular dynamic simulations complemented by MM‐GBSA calculations confirmed the significant binding of 2,4‐DTBP with Bcl‐2 (dGbind = −54.85 ± 6.79 kcal/mol) and Survivin (dGbind = −32.36 ± 1.29 kcal/mol). In vitro assays using HCT116 colorectal cancer cells revealed that 2,4‐DTBP inhibited proliferation and promoted apoptosis in both a dose‐ and time‐dependent manner. Fluorescence imaging and scanning electron microscopy illustrated the classical features associated with apoptosis upon 2,4‐DTBP exposure. Cell cycle analysis through flow cytometry highlighted a G1 phase arrest and apoptosis assay demonstrated increased apoptotic cell population. Notably, western blotting results indicated a decreased expression of Bcl‐2 and Survivin post‐treatment. Considering the cytoprotective roles of Bcl‐2 and Survivin through the inhibition of mitochondrial dysfunction, our findings of disrupted mitochondrial bioenergetics, characterized by reduced ATP production and oxygen consumption, further accentuate the functional impairment of these proteins. Overall, the integration of in silico and in vitro data suggests that 2,4‐DTBP holds promise as a therapeutic agent targeting Bcl‐2 and Survivin in colorectal cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsPhenolsHumansSurvivinMolecular Docking SimulationCell Proliferation

Stichwörter der Autor:innen

2,4-Di-tert-butylphenol (PubChem CID: 71315956)Bcl-2Survivinapoptosiscolorectal cancermitochondrial stress

Substanzen

Survivin2,4-di-tert-butylphenolPhenols

Autor:innen und Institutionen

  • Molecular Genetics and Cell Physiology Laboratory, Department of Human Physiology, Tripura University, Suryamaninagar, Tripura, India.
  • Cancer Biology Laboratory and DBT-AIST International Center for Translational and Environmental Research (DAICENTER), Department of Biosciences and Bioengineering, Indian Institute of Technology (IIT) Guwahati, Guwahati…
  • Center for Global Health Research, Saveetha Medical College and Hospital, Saveetha Institute of Medical and Technical Sciences, Chennai, Tamil Nadu, India.
  • Department of Health Sciences, Novel Global Community Educational Foundation, Hebersham, New South Wales, Australia.
  • Cell Biology and Physiology Division, CSIR-Indian Institute of Chemical Biology, Kolkata, West Bengal, India.
  • Department of Biochemistry, College of Science, King Saud University, Riyadh, Saudi Arabia.

ORCID-Profile: Nobendu Mukerjee, Arabinda Ghosh, Ajoy Kumer

Zitieren

APA

Saha, P., Hegde, M., Chakraborty, K., Singha, A., Mukerjee, N., Ghosh, D., Kunnumakkara, A. B., Khan, M. S., Ahmad, M. I., Ghosh, A., Kumer, A., & Sil, S. K. (2024). Targeted inhibition of colorectal cancer proliferation: The dual‐modulatory role of 2, 4‐DTBP on anti‐apoptotic Bcl‐2 and Survivin proteins. Journal of Cellular and Molecular Medicine, 28(7). https://doi.org/10.1111/jcmm.18150

Vancouver

Saha P, Hegde M, Chakraborty K, Singha A, Mukerjee N, Ghosh D, et al. Targeted inhibition of colorectal cancer proliferation: The dual‐modulatory role of 2, 4‐DTBP on anti‐apoptotic Bcl‐2 and Survivin proteins. Journal of Cellular and Molecular Medicine. 2024;28(7). doi:10.1111/jcmm.18150

BibTeX
@article{Saha2024,
  author = {Saha, Partha and Hegde, Mangala and Chakraborty, Kanak and Singha, Achinta and Mukerjee, Nobendu and Ghosh, Deepshikha and Kunnumakkara, Ajaikumar B and Khan, Mohd Shahnawaz and Ahmad, Md Irshad and Ghosh, Arabinda and Kumer, Ajoy and Sil, Samir Kumar},
  title = {Targeted inhibition of colorectal cancer proliferation: The dual‐modulatory role of 2, 4‐DTBP on anti‐apoptotic Bcl‐2 and Survivin proteins},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2024},
  volume = {28},
  number = {7},
  doi = {10.1111/jcmm.18150}
}
Kostenlos starten →